Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Robert H. Lurie Cancer Center
Study ID
NCT00005607
Phase
PHASE2
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic or recurrent cancer of the stomach or esophagus.

Key Dates

Start date
Feb 29, 2000
Status verified
Jul 2000

Study Design

Primary purpose
TREATMENT

Locations (4)

FacilityCityStateZIPSite coordinators
Robert H. Lurie Comprehensive Cancer Center, Northwestern UniversityChicagoIllinois60611-
Indiana University Cancer CenterIndianapolisIndiana46202-5265-
University of Pennsylvania Cancer CenterPhiladelphiaPennsylvania19104-
Vanderbilt Cancer CenterNashvilleTennessee37232-6838-

Find similar trials in Chicago, IL

By condition
Esophageal cancerGastric cancer
By specialty
OncologyGI oncology
By research site
Robert H. Lurie Comprehensive Cancer Center, Northwestern University· Chicago, ILIndiana University Cancer Center· Indianapolis, INUniversity of Pennsylvania Cancer Center· Philadelphia, PAVanderbilt Cancer Center· Nashville, TN

Related Studies